Thalomid

Type: Product

Name: Thalomid

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Aegerion Pharmaceuticals Inc

EMA backs approval of key drugs from Celgene and Aegerion

Two drugmakers reported regulatory victories for therapies in the important European market. A European Medicines Agency committee endorsed approval of Celgene's ($CELG) pomalidomide for multiple myeloma and Aegerion's ($AEGR) Lojuxta for a genetic cause ... [Published FierceBiotech - May 31 2013]

Entities: Aegerion Pharmaceuticals Inc, Celgene Corporation, European Medicines Agency, Drugs

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Celgene's Management Presents at 2013 UBS Global Healthcare Conference (Transcript)

Celgene Corporation (CELG) 2013 UBS Global Healthcare Conference Call May 22, 2013 11:30 AM ETMatt Roden - UBSHi good morning everybody. We are going to move on to the next company presenting here at the UBS Global Healthcare conference. My name is Matt ... [Published Seeking Alpha - May 22 2013]

Entities: Celgene Corporation, Abraxane, Psoriatic Arthritis, Psoriasis, Patient

First reported Mar 22 2013 - Updated Mar 22 2013 - 1 reports

Which Drugs Have the Most Patents?

Copyright © thinkBiotech This chart shows the pharmaceutical drugs with the most patents still in force. The drugs with the most active patents are COMBIVENT RESPIMAT , KALETRA , ADVAIR HFA , FLOVENT HFA , VIVITROL , THALOMID , VYVANSE ... [Published Biotech Blog - Mar 22 2013]

Entities: Drugs, Ventolin HFA, Advair HFA

First reported Feb 25 2013 - Updated Feb 25 2013 - 1 reports

Which Drugs Have the Most Patents?

Entities: Drugs, Ventolin HFA, Advair HFA

First reported Feb 04 2013 - Updated Feb 04 2013 - 1 reports

Stem Cell Boosting Treatments Can Reduce The Damaging Impact Of New Myeloma Drug On Patient Stem Cells

Myeloma treatments require a heavy artillery of novel myeloma drugs to reduce thenumber of cancer cells (ex: Revlimid, Velcade, or Thalomid), followed byhigh-dose chemotherapy to wipe out the cancer. Because the latter can completelywipe out blood-forming ... [Published Scientific Blogging - Medicine - Feb 04 2013]

Entities: Stem Cell, myeloma, high-dose chemotherapy, Drugs, Patient

First reported Jan 23 2013 - Updated Jan 23 2013 - 1 reports

Celgene Corporation

Celgene Earnings: What To Watch For

By Wall Street Trading : By Joseph Morrison Firm Overview Celgene ( CELG ) is a biotechnology company which was founded in 1986 by Dr. David Stirling, Ph.D. and Dr. Sol Barer, Ph.D. This Summit, NJ, based firm completed its IPO in 1987 and ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 23 2013]

Entities: Celgene Corporation, Doctor of Philosophy, David Stirling, Thalomid, Biotechnology

Quotes

...xenografts of little relevance to individual patients," Thomas Daniel, Celgene's president of research and early development, said in a statement. "The Presage platform addresses this challenge, permitting rapid assessment of drug candidates and combinations in relevant models, with potential to base critical drug development decisions on in vivo response data." Bluebird Bio: in March 2013 Celgene forked over an undisclosed upfront sum and agreed to pay upup to $225 million in milestones to Cambridge, MA based...

Celgene Moves Fast And Early In Expanding Its Pipeline [Published Seeking Alpha - Jun 10 2013]

More Content

sort by: Date \| Relevance
Good News for Celgene's Revlimid Zacks [Published Yahoo! Finance - Jun 17 2013]
1 Biotech, 1 Tech Stock And 1 Apparel Store Wit... [Published Seeking Alpha - Jun 10 2013]
Celgene Moves Fast And Early In Expanding Its P... [Published Seeking Alpha - Jun 10 2013]
EMA backs approval of key drugs from Celgene an... [Published FierceBiotech - May 31 2013]
Celgene's Management Presents at 2013 UBS Globa... [Published Seeking Alpha - May 22 2013]
Does Celgene Still Have Upside Potential? [Published Wall St. Cheat Sheet - May 02 2013]
Does Celgene Support All-Time Highs? [Published Wall St. Cheat Sheet - Apr 12 2013]
Which Drugs Have the Most Patents? [Published Biotech Blog - Mar 22 2013]
EntreMed to Raise $10.7m in Registered Direct O... [Published PE Hub News - Mar 04 2013]
Drug Patent Expirations for Mar 1 2013 [Published Biotech Blog - Mar 01 2013]
Which Drugs Have the Most Patents? [Published Biotech Blog - Feb 25 2013]
Stem Cell Boosting Treatments Can Reduce The Da... [Published Scientific Blogging - Medicine - Feb 04 2013]
Celgene Earnings: What To Watch For [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 23 2013]

Blogs

sort by: Date \| Relevance
Does Celgene Still Have Upside Potential? [Published Wall St. Cheat Sheet - May 02 2013] With shares of Celgene Corporation ( NASDAQ:CELG ) trading at around $117.80, is CELG an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : C = Catalyst for the Stock’s ...
Does Celgene Support All-Time Highs? [Published Wall St. Cheat Sheet - Apr 12 2013] With shares of Celgene ( NASDAQ:CELG ) trading around $123, is CELG an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Celgene is ...
Which Drugs Have the Most Patents? [Published Biotech Blog - Mar 22 2013] Copyright © thinkBiotech This chart shows the pharmaceutical drugs with the most patents still in force. The drugs with the most active patents are COMBIVENT RESPIMAT , KALETRA , ADVAIR HFA , FLOVENT HFA , VIVITROL , THALOMID , VYVANSE ...
Drug Patent Expirations for Mar 1 2013 [Published Biotech Blog - Mar 01 2013] Copyright © thinkBiotech If your reader cannot render the information below, go tohttp://www.DrugPatentWatch.com/innovation to see the latest expirationsbody { font-family:Calibri, tahoma, arial,sans-serif;}table { font-size:12px; font-family:Calibri, ...
Which Drugs Have the Most Patents? [Published Biotech Blog - Feb 25 2013] Copyright © thinkBiotech This chart shows the pharmaceutical drugs with the most patents still in force. The drugs with the most active patents are COMBIVENT RESPIMAT , KALETRA , ADVAIR HFA , FLOVENT HFA , VIVITROL , THALOMID , VYVANSE ...